Registry’s New Research Findings on Vitamin D

PNRR

Registry’s New Research Findings on Vitamin D The Foundation for Peripheral Neuropathy (FPN) started the Peripheral Neuropathy Research Registry (PNRR) in 2008. The PNRR collects data and samples (like blood and DNA) from people living with peripheral neuropathy (PN), a condition that affects the nerves and can cause pain and other issues. Why the PNRR Matters Peripheral neuropathy (PN) has many […]

Read More… from Registry’s New Research Findings on Vitamin D

November is Diabetes Awareness Month

Diabetes graphic.

Diabetes is the main cause of peripheral neuropathy. We’re supporting diabetes awareness month by promoting diabetes education. By learning about what can increase your risk of getting diabetes and the signs that show you might have it, you can take steps to prevent it or manage it better. Diabetes facts One in 10 people worldwide […]

Read More… from November is Diabetes Awareness Month

Stress and Peripheral Neuropathy

During these unprecedented times, stress has been even more prevalent in everyday life. For patients with peripheral neuropathy, it is imperative to identify the factors that are causing stress in order to help eliminate those factors as best as one can. Research published in 2017 notes that chronic stress may worsen neuropathic pain. Please be on […]

Read More… from Stress and Peripheral Neuropathy

Running Through the Pain: Finding Strength in the Face of Polyneuropathy

Marathon runner.

Boston Marathon Tragedy: A Day That Changed Everything The television flickered with images of the elite runners and the wheelchair athletes surging forward, the energy of the Boston Marathon palpable even through the screen. It was April 15, 2013, a day etched in my memory. I had watched the runners begin their journey in Hopkinton, […]

Read More… from Running Through the Pain: Finding Strength in the Face of Polyneuropathy

eNews October 2024

FPN E-News.

October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. A common treatment for breast cancer is chemotherapy, which can lead to a side effect known as chemotherapy-induced peripheral neuropathy […]

Read More… from eNews October 2024

Announcing Our New Partnership with Lilly

FPN partnerships.

We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This collaboration, with Lilly’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Collaboration for Impact with Our New […]

Read More… from Announcing Our New Partnership with Lilly

October: Breast Cancer Awareness Month

Breast cancer graphic.

October is Breast Cancer Awareness Month, a time to highlight the importance of early detection and treatment for breast cancer. In 2024, over 360,000 individuals in the U.S. will be diagnosed, making awareness and education crucial. Key Breast Cancer Facts*: The Importance of Early Detection Early detection can lead to a 99% survival rate**. A […]

Read More… from October: Breast Cancer Awareness Month

Announcing Our Renewed Partnership with Regenesis

FPN Partnership.

We are thrilled to announce Regenesis as a Champion Level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. Regenesis is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain to improve quality of life. […]

Read More… from Announcing Our Renewed Partnership with Regenesis